摘要
目的探讨布地奈德联合静脉红霉素在重症哮喘患者急诊中的应用效果。方法选取2013年10月至2015年10月收治的重症哮喘患者80例,将其随机分为两组,对照组采用红霉素治疗,实验组采用布地奈德联合静脉红霉素治疗,比较两组疗效。结果实验组总有效率为95%,显著高于对照组(85%,P<0.05);实验组咳嗽、气促、喘息及哮鸣音消失时间显著短于对照组(P<0.05)。结论重症哮喘患者采用布地奈德联合静脉红霉素治疗效果理想,值得推广应用。
Objective To observe the application effect of budesonide combined with intravenous erythromycin on emergency treatment of patients with severe asthma. Methods From October 2013 to October 2015,80 patients with severe asthma were selected in this study,they were randomly divided into the experiment group and the control group. Patients in control group were treated with aminophylline,and patients in experiment group were treated with budesonide combined with intravenous erythromyc,the clinical curative effects of the two groups were compared. Results The total efficiency of the experiment group was95%,which was significantly higher than that in the control group（ 85%,P〈0. 05）. Cough,shortness of breath,wheezing and wheezing rale disappearance time in the experiment group were significantly shorter than those in the control group（ P〈0. 05）.Conclusion The effect of budesonide combined with intravenous erythromyc on patients with severe asthma is ideal,which is worthy of popularization and application.
出处
《临床医学》
CAS
2016年第8期31-32,共2页
Clinical Medicine
关键词
布地奈德
红霉素
重症哮喘
Budesonide
Erythromycin
Severe asthma
